LOUISVILLE, Ky. (WAVE) - Scientists may be getting closer to predicting when a person at high risk for Alzheimer’s disease could begin showing symptoms.
Dr. Greg Cooper of Norton Neuroscience Institute said the findings could help identify patients on a path towards Alzheimer’s before major symptoms appear.
“One of the medicines that is most used right now to slow, slow the progression of this disease has been out for a little more than three years, not very long.
Dr. Cooper said the research is encouraging and represents an important step forward.
We should not be rushing out right now to get these tests done if we don’t have any symptoms,” Dr. Cooper explained.
LOUISVILLE, Ky. (WAVE) - Scientists may be getting closer to predicting when a person at high risk for Alzheimer’s disease could begin showing symptoms.
A new study at Columbia University found combining a blood test with genetic testing may help doctors estimate when cognitive decline could begin.
Researchers focused on a blood marker called P-TAU 217, and a genetic variant known as APOE4, both linked to a higher risk of Alzheimer’s disease.
The study found people with elevated levels of TAU and at least one copy of the APOE4 variant were more likely to develop cognitive impairment.
Some showed signs of decline within three to four years.
Dr. Greg Cooper of Norton Neuroscience Institute said the findings could help identify patients on a path towards Alzheimer’s before major symptoms appear.
“One of the medicines that is most used right now to slow, slow the progression of this disease has been out for a little more than three years, not very long. And then if we find out exactly those same types of medications can treat us and prevent symptoms from ever even starting, that, that will be a huge step forward,” he said.
Dr. Cooper said the research is encouraging and represents an important step forward. However, he added more studies are needed before doctors can use this type of testing routinely in the clinic.
“This is a significant step forward, this study. But it’s a research study. We should not be rushing out right now to get these tests done if we don’t have any symptoms,” Dr. Cooper explained. “We may get to that point, but this is hopeful for the future, but not ready for the clinic today.”
If you feel like a loved one is experiencing memory issues, experts recommend starting with your primary care provider.
